779 related articles for article (PubMed ID: 16391371)
1. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
2. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
3. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P
Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389
[TBL] [Abstract][Full Text] [Related]
4. Body mass index and risk of malignant lymphoma in Scandinavian men and women.
Chang ET; Hjalgrim H; Smedby KE; Akerman M; Tani E; Johnsen HE; Glimelius B; Adami HO; Melbye M
J Natl Cancer Inst; 2005 Feb; 97(3):210-8. PubMed ID: 15687364
[TBL] [Abstract][Full Text] [Related]
5. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
Smedby KE; Baecklund E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
[TBL] [Abstract][Full Text] [Related]
6. Ultraviolet radiation exposure and risk of malignant lymphomas.
Smedby KE; Hjalgrim H; Melbye M; Torrång A; Rostgaard K; Munksgaard L; Adami J; Hansen M; Porwit-MacDonald A; Jensen BA; Roos G; Pedersen BB; Sundström C; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Feb; 97(3):199-209. PubMed ID: 15687363
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
Ekström Smedby K; Vajdic CM; Falster M; Engels EA; Martínez-Maza O; Turner J; Hjalgrim H; Vineis P; Seniori Costantini A; Bracci PM; Holly EA; Willett E; Spinelli JJ; La Vecchia C; Zheng T; Becker N; De Sanjosé S; Chiu BC; Dal Maso L; Cocco P; Maynadié M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan JR; Breen EC; Birmann B; Grulich AE; Cozen W
Blood; 2008 Apr; 111(8):4029-38. PubMed ID: 18263783
[TBL] [Abstract][Full Text] [Related]
8. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
9. Atopy and risk of non-Hodgkin lymphoma.
Melbye M; Smedby KE; Lehtinen T; Rostgaard K; Glimelius B; Munksgaard L; Schöllkopf C; Sundström C; Chang ET; Koskela P; Adami HO; Hjalgrim H
J Natl Cancer Inst; 2007 Jan; 99(2):158-66. PubMed ID: 17227999
[TBL] [Abstract][Full Text] [Related]
10. Childhood social environment and risk of non-Hodgkin lymphoma in adults.
Smedby KE; Hjalgrim H; Chang ET; Rostgaard K; Glimelius B; Adami HO; Melbye M
Cancer Res; 2007 Nov; 67(22):11074-82. PubMed ID: 18006854
[TBL] [Abstract][Full Text] [Related]
11. Birth order, atopy, and risk of non-Hodgkin lymphoma.
Grulich AE; Vajdic CM; Kaldor JM; Hughes AM; Kricker A; Fritschi L; Turner JJ; Milliken S; Benke G; Armstrong BK
J Natl Cancer Inst; 2005 Apr; 97(8):587-94. PubMed ID: 15840881
[TBL] [Abstract][Full Text] [Related]
12. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
13. Medication use and risk of non-Hodgkin's lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Schöllkopf C; Porwit-MacDonald A; Sundström C; Tani E; d'Amore F; Melbye M; Adami HO; Glimelius B
Am J Epidemiol; 2005 Nov; 162(10):965-74. PubMed ID: 16192343
[TBL] [Abstract][Full Text] [Related]
14. Obesity and risk of non-Hodgkin lymphoma (United States).
Chiu BC; Soni L; Gapstur SM; Fought AJ; Evens AM; Weisenburger DD
Cancer Causes Control; 2007 Aug; 18(6):677-85. PubMed ID: 17484069
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.
Landgren O; Engels EA; Pfeiffer RM; Gridley G; Mellemkjaer L; Olsen JH; Kerstann KF; Wheeler W; Hemminki K; Linet MS; Goldin LR
J Natl Cancer Inst; 2006 Sep; 98(18):1321-30. PubMed ID: 16985251
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of non-Hodgkin lymphoma.
Grulich AE; Vajdic CM
Pathology; 2005 Dec; 37(6):409-19. PubMed ID: 16373224
[TBL] [Abstract][Full Text] [Related]
17. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
18. B-cell lymphoproliferation in chronic inflammatory rheumatic diseases.
Hansen A; Lipsky PE; Dörner T
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):561-9. PubMed ID: 17906611
[TBL] [Abstract][Full Text] [Related]
19. Nutrients contributing to one-carbon metabolism and risk of non-Hodgkin lymphoma subtypes.
Koutros S; Zhang Y; Zhu Y; Mayne ST; Zahm SH; Holford TR; Leaderer BP; Boyle P; Zheng T
Am J Epidemiol; 2008 Feb; 167(3):287-94. PubMed ID: 17989056
[TBL] [Abstract][Full Text] [Related]
20. Tobacco use and non-Hodgkin lymphoma: results from a population-based case-control study in the San Francisco Bay Area, California.
Bracci PM; Holly EA
Cancer Causes Control; 2005 May; 16(4):333-46. PubMed ID: 15953976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]